update on tirzepatide lawsuit Zepbound [2026] Tirzepatide Lawsuit Against the FDA:

Patients on tirzepatide should know that any unexplained abdominal pain, especially if paired with digestive distress or fever, requires urgent medical attention and temporary discontinuation of the medication

Some doses of Mounjaro and Zepbound are expected to be available in limited quantities through the second quarter, according to the FDA.

Is compounded tirzepatide safer to use while nursing

This reduction in desire for highly palatable food items further underscores the capacity of GLP-1 RA-based interventions to not only suppress appetite but also to selectively modulate food preferences, contributing to sustained dietary changes and weight management

Graphical abstract was created by BioRender ( Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

Compounded programs also vary